NAD+ IV Therapy for Anti-Aging: Mechanisms, Evidence, and Whether It Is Worth It

NAD+ IV therapy for anti-aging is an intravenous drip of nicotinamide adenine dinucleotide, typically 250 to 1,000 mg infused over 2 to 4 hours, used to restore NAD+ levels that fall with age. The biology behind it (sirtuins, mitochondria and DNA repair) is well studied, but no published randomized trial shows that IV NAD+ slows aging in people, and the FDA has not approved it for anti-aging or any other use.

NAD+ IV therapy, also called an NAD drip or NAD+ infusion, has moved from niche addiction recovery clinics into mainstream longevity medicine faster than the clinical evidence has been able to keep pace. The biochemistry is real and the mechanistic rationale is solid. The clinical evidence for anti-aging specifically is still building. Knowing what is measured in people versus what is extrapolated from mouse studies is the difference between an informed decision and an expensive guess.

What NAD+ Is and Why It Declines

NAD+ is a coenzyme found in every cell of the body. It exists in two primary forms: NAD+ (oxidized) and NADH (reduced). The ratio between these forms is central to cellular energy metabolism. As an electron carrier in the mitochondrial electron transport chain, NAD+ is the essential link between the food we eat and the ATP our cells run on.

Beyond energy metabolism, NAD+ is a substrate for three classes of enzymes with direct relevance to aging: sirtuins (SIRT1-7), which regulate gene expression, inflammation, and stress responses; PARPs (poly-ADP-ribose polymerases), which repair broken DNA strands; and CD38, which uses NAD+ as a substrate in immune signaling but contributes to age-related NAD+ decline.

NAD+ levels fall with age due to several mechanisms: increased consumption by PARPs (more DNA damage with age means more repair activity), increased CD38 activity (chronic inflammation drives CD38 expression), reduced production from dietary precursors, and mitochondrial dysfunction creating a self-reinforcing cycle. In people, Massudi et al. (2012) in PLoS One found that NAD+ in human skin tissue fell steadily with age while PARP activity rose, which fits the consumption model.

A landmark 2013 study by Gomes et al. in Cell, from David Sinclair's lab at Harvard Medical School, showed that raising NAD+ in 22 month old mice with NMN restored many markers of mitochondrial function and muscle health to levels seen in young mice. That result generated enormous scientific and popular interest in NAD+ repletion strategies, including intravenous NAD+.

Sirtuin Activation and the Anti-Aging Mechanism

Sirtuins, sometimes called the “longevity enzymes,” require NAD+ to function. SIRT1 and SIRT3 are the most studied in the context of aging. SIRT1 deacetylates and activates PGC-1 alpha, the master regulator of mitochondrial biogenesis, stimulating the cell to make new, healthier mitochondria. It also activates FOXO transcription factors that regulate stress resistance and apoptosis, and modulates NF-kB to reduce chronic inflammation.

SIRT3 is located in the mitochondria and deacetylates key enzymes in the electron transport chain and TCA cycle, improving their efficiency and reducing superoxide production. SIRT3 deficiency in animal models accelerates aging phenotypes; its activation is associated with reduced age-related hearing loss, metabolic protection, and tumor suppression.

The practical implication: if NAD+ levels are insufficient, sirtuins are substrate-limited and cannot perform these functions at adequate levels. Restoring NAD+ removes the bottleneck. Whether this translates to meaningful longevity outcomes in humans is the open question, and it is the same question for IV NAD+, oral precursors and adjacent longevity approaches such as rapamycin and senolytics.

IV vs. Oral: The Bioavailability Question

This is where the debate between IV NAD+ and oral precursors like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) becomes practically important.

Why IV Has Higher Bioavailability

NAD+ does not cross cell membranes directly. When taken orally, NAD+ is broken down in the gut and liver into nicotinamide before being re-synthesized into NAD+ inside cells. Some of the nicotinamide is converted to N-methylnicotinamide (MeNAM), which is excreted in urine. IV delivery bypasses gut degradation and puts the full dose into the bloodstream.

Full delivery to the blood is not the same as full delivery into cells. In a pilot study of a slow six hour IV NAD+ infusion, Grant et al. (2019) in Frontiers in Aging Neuroscience found that plasma NAD+ and its metabolites did not change for the first 2 hours, meaning the infused NAD+ was rapidly removed from the blood, likely broken down by enzymes such as CD38 or taken up by tissues. NAD+ and MeNAM then appeared in urine. No published trial has compared IV NAD+ head to head with oral NMN or NR for anti-aging outcomes.

Form	Bioavailability	Speed of Action	Duration	Cost	Evidence Level
IV NAD+	100% (direct)	Hours	Days to weeks	$250-$1,000/session	Moderate (mechanistic), Emerging (anti-aging)
NMN (oral)	Moderate (gut conversion)	Days	Sustained with daily use	$50-$150/month	Emerging
NR (oral)	Moderate (gut conversion)	Days	Sustained with daily use	$40-$100/month	Emerging
Niacinamide (oral)	High	Days	Sustained with daily use	$5-$20/month	Preliminary for NAD+ elevation

NMN and NR: The Oral Alternatives

NMN is a direct precursor to NAD+ in the salvage pathway. In a 10 week randomized trial in postmenopausal women with prediabetes, Yoshino et al. (2021) in Science, with Shin-ichiro Imai of Washington University, found that 250 mg/day of oral NMN increased muscle insulin sensitivity. Igarashi et al. (2022) in npj Aging gave healthy older men 250 mg/day of NMN for 6 or 12 weeks and found that whole blood NAD+ rose significantly.

The largest dose finding trial so far, Yi et al. (2023) in GeroScience, randomized 80 healthy middle-aged adults to placebo or 300, 600 or 900 mg/day of NMN for 60 days. Blood NAD+ rose in a dose-dependent way, and the authors reported the best combination of NAD+ increase and walking performance at 600 mg/day.

NR (nicotinamide riboside) converts to NMN before becoming NAD+. Multiple human RCTs confirm that oral NR at 250-1,000mg/day raises blood NAD+ levels. In a crossover trial of 24 healthy middle-aged and older adults, Martens et al. (2018) in Nature Communications found NR at 1,000 mg/day for 6 weeks was well tolerated and raised NAD+ in blood cells. These are meaningful increases, though whether they translate to clinical outcomes remains under investigation. A deeper comparison sits in our post on NAD+ IV versus oral supplements.

Clinical Evidence for Anti-Aging and Longevity

The honest answer requires separating strong mechanistic evidence from still-developing clinical outcome evidence.

In animal models, NAD+ repletion via NMN or NR supplementation consistently improves markers of muscle function, metabolic health, and in some studies lifespan. The results in mice have been replicated across dozens of studies and are scientifically accepted. The translation to humans is less certain.

Human clinical trials are showing promising but not yet definitive results, and almost all of them test oral precursors rather than IV NAD+. In the Igarashi et al. (2022) trial of older men, 250 mg/day of NMN produced nominally significant improvements in gait speed and grip strength that the authors said need validation in larger studies, with no change in body composition. In Yi et al. (2023), larger rises in blood NAD+ tracked with longer six minute walk distances. These are among the most clinically meaningful human data to date, though the samples were modest and the follow up was weeks, not years.

For IV NAD+ specifically, controlled trial data is limited. Most IV NAD+ evidence comes from its original application in addiction recovery, from small pharmacokinetic studies such as Grant et al. (2019), and from observational experience in longevity clinics. There is no published Phase III RCT of IV NAD+ for anti-aging outcomes.

What the evidence does not show yet

No human study has shown that IV NAD+ extends lifespan, lowers biological age on a validated clock, or prevents age-related disease. No study has established how long a rise in NAD+ after an infusion lasts inside tissues, or which dose and schedule matter. Registered trials on ClinicalTrials.gov are a better guide to what is being tested than clinic marketing.

What IV NAD+ Is Being Used For

In clinical practice, IV NAD+ is currently most commonly used for the following applications, with varying levels of supporting evidence:

• Energy and cognitive performance: Many patients report improvements in mental clarity, energy, and mood after a series of IV NAD+ infusions. These reports are anecdotal and lack placebo-controlled trial support for cognitive aging specifically; our post on NAD+ for brain fog covers that question in detail.
• Athletic recovery and performance: NAD+ is central to mitochondrial energy metabolism, and faster ATP regeneration theoretically supports exercise recovery. Athletes using IV NAD+ report reduced post-exercise fatigue, though controlled data is limited.
• Substance use recovery: IV NAD+ has the longest clinical history here, with use in alcohol and opioid withdrawal programs going back decades. Published support consists mostly of small open-label reports and clinic case series, and large RCTs are still lacking. Evidence-based options are covered in our guide to addiction treatment.
• General longevity protocols: Longevity-focused clinics typically incorporate IV NAD+ into broader anti-aging protocols alongside other interventions such as peptide therapy, hormone replacement therapy and glutathione or IV vitamin therapy.

Some clinics also offer IV NAD+ to people with chronic fatigue syndrome or long COVID fatigue. Controlled human evidence for these uses is thin, and a primary care physician or specialist should rule out treatable causes of fatigue first.

Typical Protocols

IV NAD+ protocols vary by clinical indication and dose tolerance. No regulator or professional society publishes a standard anti-aging dose. The following parameters reflect typical practice at established longevity clinics:

Initial Loading Series (Anti-Aging / Energy)

• Dose: 250-750mg per session (some clinics use up to 1,000mg)
• Duration: 2-4 hours per infusion (slow infusion required to minimize side effects)
• Frequency: Daily or every-other-day for 4-10 sessions
• Total initial course: 1-3 grams over 1-2 weeks

Maintenance Protocol

• Dose: 500-1,000mg per session
• Frequency: Monthly to quarterly, depending on response and goals
• Often combined with oral NMN or NR between infusions for sustained NAD+ elevation

The table below summarizes the same clinic protocols side by side.

What to expect during an infusion

The most common side effect during infusion is a sensation of chest tightness, nausea, or a “funny feeling” in the chest. These are dose-rate dependent: slowing the infusion usually resolves them, which is why NAD+ drips run much longer than a standard vitamin IV. Flushing, cramping and fatigue afterward are also common, partly related to nicotinamide activity. Patients with an underlying arrhythmia need monitoring during the drip. Our post on NAD+ dosage covers how clinics adjust rate and dose.

Safety Considerations

IV NAD+ is generally well tolerated in published reports and clinic experience, though the formal safety data come from small studies rather than large trials. NAD+ is a molecule the body makes itself, but an intravenous preparation is still a compounded injectable that needs medical screening. Precautions include:

• Patients with active cardiac arrhythmias should be monitored during infusion, as rapid NAD+ infusion can cause palpitations
• Blood pressure may fluctuate during infusion; patients with labile hypertension should be monitored
• NAD+ is a substrate for PARP enzymes involved in DNA repair; theoretical concerns about supporting tumor repair in active cancer have been raised, though this is unproven at clinical doses. Oncology consultation is advisable for cancer patients
• The IV preparation must be pharmaceutical grade. Impure NAD+ preparations have caused adverse reactions. A compounding pharmacy with sterility and potency testing documentation is required

Who should avoid or delay NAD+ IV therapy?

People who are pregnant or breastfeeding should avoid NAD+ IV therapy because there are no safety data for those groups. People with active cancer, unstable heart rhythm, uncontrolled blood pressure, or significant kidney or liver disease should get clearance from their own physician first. Anyone taking several medications should share the full list with the prescribing clinician before the first infusion.

How is IV NAD+ regulated?

The FDA has not approved any NAD+ injection for anti-aging, fatigue or addiction. Clinics obtain IV NAD+ from compounding pharmacies, either 503A pharmacies that prepare medicines for individual prescriptions or 503B outsourcing facilities registered with the FDA. State medical and nursing boards govern who may order and administer IV infusions, so the rules differ from state to state.

Who Provides NAD+ IV Therapy and How to Choose a Clinic

NAD+ IV therapy is ordered by a licensed prescriber, usually a physician (MD or DO), nurse practitioner or physician assistant, and in some states a naturopathic doctor. A registered nurse typically places the IV line and monitors the infusion. It is offered by longevity and anti-aging clinics, integrative and functional medicine practices, IV infusion lounges and some addiction recovery programs.

A well run clinic will screen your health history and medications before the first infusion, name the pharmacy that compounds its NAD+, share a certificate of analysis on request, and explain how it adjusts infusion speed when side effects appear. It should also be clear that the treatment is cash pay and that anti-aging benefit in humans is not established.

You can compare providers in the national directory of NAD+ IV therapy clinics, and read how the treatment works in our NAD+ IV therapy treatment guide. Listing order in the directory is not paid ranking. Featured slots are clearly labeled and capped, and Verified means a clinic has completed our credential checks, not that it paid for placement. Regenerated.com is free for patients, and inclusion in the directory is not an endorsement. The differences are explained in our guide to Featured, Verified and organic listings.

Cost and Making the Decision

A single IV NAD+ infusion costs $250-$1,000 depending on dose, location, and whether additional nutrients (glutathione, B vitamins, vitamin C) are included. A loading series of 5-10 infusions runs $1,500-$8,000. Insurance does not cover NAD+ therapy for anti-aging indications. Price drivers are covered in our breakdown of NAD+ IV therapy cost.

For budget-conscious patients, oral NMN or NR at evidence-based doses (250-500mg/day) achieves meaningful NAD+ elevation at $50-$150/month and has a growing human RCT evidence base. IV NAD+ makes most sense for people who want rapid, high-magnitude repletion, have already tried oral precursors without adequate response, or have specific clinical indications like addiction recovery or severe fatigue states.

Is NAD+ IV therapy worth it for anti-aging?

The honest bottom line on NAD+ IV therapy: the mechanistic rationale is sound, the safety record is good, and the early human evidence is promising. The large-scale clinical outcome data that would allow a definitive evidence grade for anti-aging is still being generated. Patients who use it based on current evidence are making a reasonable bet, not a proven intervention.

For more on IV therapies and longevity strategies, see our guides to IV and infusion therapies and our overview of longevity and anti-aging approaches.

Frequently asked questions

Does NAD+ IV therapy work for anti-aging?

NAD+ IV therapy reliably delivers NAD+ into the bloodstream, but no published randomized trial shows that it slows aging in people. The case for it rests on animal research such as Gomes et al. (2013) in Cell and on small human studies, most of which tested oral NMN or NR rather than IV NAD+. Many patients report more energy and clearer thinking after a series of infusions, but those reports are not placebo controlled.

How much NAD+ is in an anti-aging IV infusion?

Most clinics infuse 250 to 750 mg of NAD+ per session during an initial loading series, and some go up to 1,000 mg. Maintenance infusions are usually 500 to 1,000 mg. Each drip runs 2 to 4 hours because a faster rate commonly causes chest tightness, nausea and flushing. No regulator or professional society sets a standard anti-aging dose, so the dose is a clinical judgment by the prescriber.

How often should you get NAD+ IV therapy for anti-aging?

A typical clinic schedule is a loading series of 4 to 10 infusions given daily or every other day over 1 to 2 weeks, followed by maintenance infusions monthly or quarterly. Many clinics add oral NMN or NR between visits to keep NAD+ levels up. These schedules come from clinic practice, not from trials that compared one schedule with another, so frequency should be agreed with the prescriber.

Is NAD+ IV better than NMN or NR supplements?

IV NAD+ raises blood NAD+ faster, but oral NMN and NR have more randomized human trials behind them and cost far less. Trials such as Yi et al. (2023) in GeroScience and Martens et al. (2018) in Nature Communications show oral precursors raising blood NAD+ over weeks. Grant et al. (2019) found infused NAD+ is cleared from plasma quickly, and no trial has compared IV and oral forms head to head for aging outcomes.

What are the side effects of NAD+ IV therapy?

The most common side effects of NAD+ IV therapy are chest tightness, nausea, flushing, abdominal cramping and a heavy or anxious feeling during the drip. They are rate dependent and usually ease when the infusion is slowed. Palpitations and blood pressure changes can occur, so people with arrhythmia or unstable blood pressure need monitoring. Bruising or irritation at the IV site is possible, and product quality depends on the compounding pharmacy.

Is NAD+ IV therapy FDA approved or covered by insurance?

No. The FDA has not approved NAD+ IV therapy for anti-aging or any other indication, and clinics source it from compounding pharmacies. Insurance plans do not cover it for anti-aging, so patients pay cash, with clinics quoting $250 to $1,000 per infusion. Before booking, ask for a written quote that lists the dose, the infusion time and any add-on nutrients.

---

Related Reading

• IV Therapy: Types, Evidence, Costs, and How to Choose a Provider
• NAD+ IV Therapy: The Complete Science-Based Guide to Benefits, Cost, Evidence, and What to Expect

More on peptides and metabolic health

• Sermorelin Therapy
• Tesamorelin for Visceral Fat